A few key points:
- The FDA study does indeed replicate the positive results of the original XMRV study, showing XMRV in the blood of CFS patients.
- Andrea Whittemore, daughter of the founders of the Whittemore-Peterson Institute, is already "significantly improved" on treatments for XMRV.
- Another paper due out at the end of the year will show that XMRV causes immune system abnormalities.
- Several drugs have already been shown to be effective against XMRV in the laboratory.
- Pharmaceutical companies that halted their work based on earlier negative studies have resumed work on medications to treat XMRV, including many that are already on the market.
- Treatment trials with real patients should begin soon at WPI.